Quantum BioPharma Total Liabilities

Quantum BioPharma (QNTM) currently reports a total liabilities of $16M as of March 2026. That compares with $10M in the prior-year period — up 58.5% year over year. Use the charts on this page to explore Quantum BioPharma's total liabilities history and peer comparisons.

Quantum BioPharma's total liabilities increased from $10M to $16M — a 58.5% year-over-year increase (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Quantum BioPharma reported $16M in total liabilities as of March 2026. That compares with $10M in the prior-year period — up 58.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total liabilities of $16M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Quantum BioPharma, and consider following QNTM for alerts when major investors trade the stock.